Ariadne Diagnostics, LLC (Ariadne-Dx) is a diagnostic discovery and development company that utilizes integrated bioinformatics tools to identify novel biomarker panels for the advancement of prognostic and predictive tests in areas of unmet medical need. The company does not confine itself to the use of specific diagnostic platforms and employs modern genomic, proteomic and metabolomic tools in its diagnostic development, often incorporating biomarkers at the DNA, RNA and protein levels simultaneously to create its diagnostic panels.
Internal research and development at Ariadne-Dx is primarily focused on the development of companion diagnostics (CDx) for both cancer and neuromuscular/neurodegenerative disorders.
Role within NeuromicsIdentify functional pathways, potential biomarkers and data outflow integration.
Develop in silico models for development of appropriate preventive or therapeutic personalized interventions.
Related projects